Skip to main content
Clinical Trials/NCT06061601
NCT06061601
Completed
Not Applicable

Use of a Lower Limb Exoskeleton in Locomotor Rehabilitation of Stroke Patients: Feasibility, Safety and a Pilot Clinical Study

Fondazione Don Carlo Gnocchi Onlus1 site in 1 country10 target enrollmentApril 12, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke Sequelae
Sponsor
Fondazione Don Carlo Gnocchi Onlus
Enrollment
10
Locations
1
Primary Endpoint
Change in meters walked during the Two minute walking test
Status
Completed
Last Updated
last year

Overview

Brief Summary

Walking difficulties are common symptoms after stroke, significantly reducing quality of life. Walking recovery is therefore one of the main priorities of rehabilitation. Wearable powered exoskeletons have been developed to provide lower limb assistance and enable training for persons with gait impairments by using typical physiological movement patterns. Exoskeleton were originally designed for individuals without any walking capacities, such as subjects with a complete spinal cord injury. Recent systematic reviews suggested that lower limb exoskeletons could be valid tools to restore independent walking in subjects with residual motor function, such as persons post-stroke.The aim of the study was to identify the end-users needs and to develop a user-centered-based control system for the TWIN lower limb exoskeleton to provide an efficient post-stroke rehabilitation of gait. The investigators thus carried out the development and validation through evaluation sessions performed on healthy clinical experts and persons with stroke to evaluate TWIN-Acta usability, acceptability, and barriers of usage. A phase two includes a pilot study of efficacy of using the TWINActa for gait rehabilitation for persons with stroke.

Detailed Description

The aim of the study was to identify the end-users needs and to develop a user-centered-based control system for the TWIN lower limb exoskeleton to provide post-stroke rehabilitation. The investigators thus carry out the development and validation of TWIN-Acta: a novel control suite for TWIN, specifically designed for gait rehabilitation of persons post stroke through use of typical physiological movement patterns. The study will be carried out in two phases. In the first user-centered developmental phase data on usability, acceptability, and limitations to system usage will be collected from clinical experts and persons with stroke through questionnaires and semi-structured interviews.This developmental phase will follow a user-centered approach: it will be based on focus group sessions with clinical and biomechanical experts to define the design specifications for the new control modality of the exoskeleton; consequently evaluation sessions consisting of physical testing of the TWIN-Acta will be carried out by healthy clinical experts and persons with stroke to evaluate TWIN-Acta usability, acceptability, and barriers of usage. In the second phase of the study a pilot study including 20 sessions of gait rehabilitation of persons at least three month post stroke will be carried out in clinic with the TWIN exoskeleton including the TWIN-Acta control suite. Outcomes will be verified at baseline and following the intervention through feasibility measures, patient reported outcomes, clinical measures of gait ability and through EMG and 3D gait analysis. The quantitative values will be compared to data of healthy controls walking in the exoskeleton in one session but not receiving any intervention.

Registry
clinicaltrials.gov
Start Date
April 12, 2021
End Date
July 31, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Healthy subjects
  • Age 30-75 anni;
  • 50 kg ≤ weight ≤90 kg
  • 150 cm ≤ height ≤ 192 cm
  • Thigh length: 355 ÷ 475 mm;
  • Length of tibia: 405 ÷ 485 mm;
  • Width pelvis: 690 ÷ 990 mm;
  • Shoe number: 36 ÷ 45
  • Subjects with stroke
  • Age 30-75 anni;

Exclusion Criteria

  • Healthy subjects
  • Prosthetic implants
  • Musculoskeletal, neurological, cardiovascular and pulmonary disorders that may impair gait;
  • State of pregnancy or breastfeeding.
  • Exclusion criteria
  • Subjects with stroke
  • Mini Mental State Examination \< 23/30;
  • Clinical records of visuospatial and ideomotor apraxia, behavioral disorders (e.g. depression, aggression), neglect, major visual impairment and severe osteoporosis;
  • Non stabilized fractures;
  • Cranial injury;

Outcomes

Primary Outcomes

Change in meters walked during the Two minute walking test

Time Frame: Baseline (T0) and after 4 weeks (T1) and after 3 months (T2)

The subjects were instructed to walk at their usual speed for 2 minutes while the distance they covered in 2 minutes was recorded in meters.

Secondary Outcomes

  • Change in score on the Ashworth scale(Baseline (T0) and after 4 weeks (T1))
  • Change in score on the Stroke impact Scale (SIS) questionnaire(Baseline (T0) and after 4 weeks (T1) and after 3 months (T2))
  • Changes in movement parameters extracted from the kinematics of the body.(Baseline (T0) and after 4 weeks (T1))
  • Change in time (sec) taken to complete the 10 meter walking test (10mwt)(Baseline (T0) and after 4 weeks (T1) and after 3 months (T2))
  • Change in time (sec) taken to Timed up and Go(Baseline (T0) and after 4 weeks (T1))
  • Change in score on the Muscle Manual Test (MMT)(Baseline (T0) and after 4 weeks (T1))
  • Change time (sec) taken to complete the Five time sit to stand (5xSTS)(Baseline (T0) and after 4 weeks (T1) and after 3 months (T2))
  • Correlation between brain activity parameters and motor activity parameters(Baseline (T0) and after 4 weeks (T1))

Study Sites (1)

Loading locations...

Similar Trials